# Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/7ccd91ae-2b6a-43f7-acc5-6c182cec0d11

> Inspection records and compliance data for Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. in Changzhou, None. Access full analysis and detailed observations.

---

## Details

- Name: Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
- FEI Number: 3001599766
- City: Changzhou
- State: None
- Country Name: China
- Address Line 1: No. 302 Huzhuangtou, Sanhuangmiao, Zhenglu, Tianning
- Zip Code: None

## Related Documents

- [483 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - Unknown Date](https://www.keypedia.com/records/483/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/88731eb4-5ab6-4b2a-b83c-bc408946c100) — source: FDA, date: Invalid Date
- [FDA Inspection 1291762 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2025-09-12](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/c2c213cd-18f2-411d-ae2c-0cdf6a37b1b1) — source: FDA, date: September 12, 2025
- [FDA Inspection 1291762 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2025-09-12](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/28070106-55e4-4159-8861-a6c254b34e93) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 12, 2025
- [FDA Inspection 1064555 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2018-07-26](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/76f31d23-dc60-4c76-a4bd-6bd188cf3544) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2018
- [FDA Inspection 886759 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2014-06-12](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/4c1da626-2c55-4542-a1dd-225782a2a583) — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2014
- [FDA Inspection 728837 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2011-04-28](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/1a0acf84-58b5-412d-b164-2149f201c646) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2011
- [FDA Inspection 615933 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. - 2009-09-17](https://www.keypedia.com/records/fda_inspections/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/a43f36d9-7e56-49f4-8620-60871db3a12c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 17, 2009

## Related Companies

- [Sigma-Aldrich Manufacturing LLC](https://www.keypedia.com/companies/sigma-aldrich-manufacturing-llc/e6637246-5655-4a30-849d-a25e3a5cd06c)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/fc196e7f-0f5e-4ef1-afa6-3023ca6df1f3)
- [SCI Pharmtech Inc.](https://www.keypedia.com/companies/sci-pharmtech-inc/38edf740-19b5-4fbf-bd65-e8cd87a7b1db)
- [Patheon Austria GmbH & Co. KG](https://www.keypedia.com/companies/patheon-austria-gmbh-co-kg/739a9a3f-4e77-4ff0-bf6e-fc2d5a48b5f3)
- [Kyongbo Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/kyongbo-pharmaceutical-co-ltd/6b8fd90f-4fa3-4c7b-9ed6-a8a8f4b511da)
- [Partner Therapeutics Inc](https://www.keypedia.com/companies/partner-therapeutics-inc/837081c1-0ffa-4c06-94c1-4ce65e130882)
- [Signa S.A. de C.V.](https://www.keypedia.com/companies/signa-sa-de-cv/378a704e-5acb-49b8-9cd6-32503b29b3fc)
- [Roche Diagnostics GmbH](https://www.keypedia.com/companies/roche-diagnostics-gmbh/a09aff2c-624a-48aa-b33e-fae16aa146f8)
- [Yuhan Chemical, Inc.](https://www.keypedia.com/companies/yuhan-chemical-inc/ab32ef04-730e-4d05-a241-f163d065a70d)
- [Chattem Chemicals, Inc.](https://www.keypedia.com/companies/chattem-chemicals-inc/c90cf934-de91-4e46-8d41-bc6df242a518)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/truong-xuan-nguyen/4ccdfd9f-f002-4498-829e-6e951e9d5e43)